-
EP2255805
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2255805
| EP2255805 - Deferasirox for the treatment of hereditary hemochromatosis [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.10.2011 Database last updated on 13.11.2024 | Most recent event Tooltip | 28.10.2011 | Application deemed to be withdrawn | published on 30.11.2011 [2011/48] | Applicant(s) | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MT
NL
PL
PT
RO
SE
SI
SK
TR
Novartis AG Lichtstrasse 35 4056 Basel / CH | For:AT
Novartis Pharma AG Brunner Strasse 59 1230 Vienna / AT | [2010/48] | Inventor(s) | 01 /
Nick, Hanspeter In den Gärten 8b 4202, Duggingen / CH | 02 /
Rojkjaer, Lisa 84 Clover Lane Princeton, NJ 08540 / US | 03 /
Bodner, Janet 14 Mine Mount Road Bernardsville, NJ 07924 / US | 04 /
Marks, Peter Wayne 145 Rimmon Road Woodbridge, CT 06525-1913 / US | [2011/08] |
| Former [2010/48] | 01 /
Nick, Hanspeter In den Gärten 8b 4202, Duggingen / CH | ||
| 02 /
Rojkaer, Lisa 84 Clover Lane Princeton, NJ 08540 / US | |||
| 03 /
Bodner, Janet 14 Mine Mount Road Bernardsville, NJ 07924 / US | |||
| 04 /
Marks, Peter Wayne 145 Rimmon Road Woodbridge, CT 06525-1913 / US | Representative(s) | Roth, Peter Richard, et al Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
| Former [2010/48] | Roth, Peter Richard, et al Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 10174063.7 | 21.05.2007 | [2010/48] | Priority number, date | US20060835658P | 04.08.2006 Original published format: US 835658 P | US20060803049P | 24.05.2006 Original published format: US 803049 P | US20060747974P | 23.05.2006 Original published format: US 747974 P | [2010/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2255805 | Date: | 01.12.2010 | Language: | EN | [2010/48] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.10.2010 | Classification | IPC: | A61K31/4196, A61P3/12, A61P43/00 | [2010/48] | CPC: |
A61K31/4196 (EP,KR,US);
C07D249/06 (KR);
A61P3/00 (EP);
A61P3/12 (EP);
A61P39/04 (EP);
A61P43/00 (EP);
A61P7/00 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2010/48] | Extension states | HR | Not yet paid | Title | German: | Deferasirox zur Behandlung ererbter Hämochromatose | [2010/48] | English: | Deferasirox for the treatment of hereditary hemochromatosis | [2010/48] | French: | Déférasirox pour le traitement de l'hémochromatose héréditaire | [2010/48] | Examination procedure | 02.06.2011 | Application deemed to be withdrawn, date of legal effect [2011/48] | 15.07.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2011/48] | Parent application(s) Tooltip | EP07840190.8 / EP2026801 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070840190) is 21.10.2010 | Fees paid | Renewal fee | 27.12.2010 | Renewal fee patent year 03 | 27.12.2010 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.05.2011 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2005097062 (NOVARTIS AG [CH], et al); | by applicant | WO9749395 | US6465504 |